SGCB and hydrops fetalis: Recently, the treatment of HF has entered a multi-mechanism and multi-target stage with the introduction of new drugs, including ARNI (instead of ACEI/ARB in golden triangle combination), SGLT-2i, sGC agonist, the cardiac hyperpolarization-activated funny current (If) inhibitor and myosin agonist etc [62].